GLS and Alzheimer disease: The overexpression of glutaminase C (GAC), present in early stages of AD-like pathology in mouse brains, promotes microglial pro-inflammatory activation and induces release of EVs that contain increased levels of pro-inflammatory miRNAs and decreased levels of anti-inflammatory miRNAs (Gao et al., 2019) (Figure 3).